Epigenetics and cerebral organoids: promising directions in autism spectrum disorders

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Autism spectrum disorder (ASD) affects 1 in 68 children, characterized by social/communication impairments and repetitive behaviors.
• Current treatments alleviate symptoms but do not cure ASD, highlighting the need for deeper understanding of its complex causes.
• Both genetic and environmental factors, including prenatal exposures and birth complications, are implicated in ASD etiology.

Purpose of the Study:

• To review current knowledge on epigenetic alterations in ASD.
• To explore the potential of novel 3D stem cell models, specifically brain organoids, for studying ASD mechanisms.
• To bridge the gap between genetic and environmental factors in understanding autism neurobiology.

Main Methods:

• Review of existing literature on epigenetics and ASD.
• Discussion of epigenome-wide association studies (EWAS) limitations with postmortem samples.
• Introduction of 3D brain organoid technology as a cellular model for in vitro study.

Main Results:

• Epigenetic alterations, such as DNA methylation differences, are observed in ASD candidate genes.
• Limited availability of suitable cellular models hinders the study of early epigenetic changes in ASD.
• 3D brain organoids provide a promising in vitro platform to model neurodevelopment and investigate epigenetic modifications.

Conclusions:

• Epigenetic changes are crucial for understanding the interplay between genes and environment in ASD.
• 3D brain organoids represent a significant advancement for studying the neurobiological underpinnings of autism.
• This approach can elucidate critical epigenetic alterations during neurodevelopment relevant to ASD.